1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Monoclonal Antibody Therapy Revenue
1.4 Market by Type
1.4.1 Global Monoclonal Antibody Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Recombinant
1.4.3 Chimeric
1.4.4 Humanized
1.4.5 Human
1.5 Market by Application
1.5.1 Global Monoclonal Antibody Therapy Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic Test
1.5.3 Analytical And Chemical Uses
1.5.4 Cancer Treatment
1.5.5 Autoimmune Diseases
1.5.6 Hematological Disorders
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Therapy Market Perspective (2015-2026)
2.2 Global Monoclonal Antibody Therapy Growth Trends by Regions
2.2.1 Monoclonal Antibody Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Monoclonal Antibody Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Monoclonal Antibody Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Monoclonal Antibody Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Monoclonal Antibody Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Therapy Players by Market Size
3.1.1 Global Top Monoclonal Antibody Therapy Players by Revenue (2015-2020)
3.1.2 Global Monoclonal Antibody Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Monoclonal Antibody Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Monoclonal Antibody Therapy Market Concentration Ratio
3.2.1 Global Monoclonal Antibody Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Therapy Revenue in 2019
3.3 Monoclonal Antibody Therapy Key Players Head office and Area Served
3.4 Key Players Monoclonal Antibody Therapy Product Solution and Service
3.5 Date of Enter into Monoclonal Antibody Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Monoclonal Antibody Therapy Historic Market Size by Type (2015-2020)
4.2 Global Monoclonal Antibody Therapy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Monoclonal Antibody Therapy Market Size by Application (2015-2020)
5.2 Global Monoclonal Antibody Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Monoclonal Antibody Therapy Market Size (2015-2020)
6.2 Monoclonal Antibody Therapy Key Players in North America (2019-2020)
6.3 North America Monoclonal Antibody Therapy Market Size by Type (2015-2020)
6.4 North America Monoclonal Antibody Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Monoclonal Antibody Therapy Market Size (2015-2020)
7.2 Monoclonal Antibody Therapy Key Players in Europe (2019-2020)
7.3 Europe Monoclonal Antibody Therapy Market Size by Type (2015-2020)
7.4 Europe Monoclonal Antibody Therapy Market Size by Application (2015-2020)
8 China
8.1 China Monoclonal Antibody Therapy Market Size (2015-2020)
8.2 Monoclonal Antibody Therapy Key Players in China (2019-2020)
8.3 China Monoclonal Antibody Therapy Market Size by Type (2015-2020)
8.4 China Monoclonal Antibody Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Monoclonal Antibody Therapy Market Size (2015-2020)
9.2 Monoclonal Antibody Therapy Key Players in Japan (2019-2020)
9.3 Japan Monoclonal Antibody Therapy Market Size by Type (2015-2020)
9.4 Japan Monoclonal Antibody Therapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Monoclonal Antibody Therapy Market Size (2015-2020)
10.2 Monoclonal Antibody Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Monoclonal Antibody Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Monoclonal Antibody Therapy Market Size by Application (2015-2020)
11 India
11.1 India Monoclonal Antibody Therapy Market Size (2015-2020)
11.2 Monoclonal Antibody Therapy Key Players in India (2019-2020)
11.3 India Monoclonal Antibody Therapy Market Size by Type (2015-2020)
11.4 India Monoclonal Antibody Therapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Monoclonal Antibody Therapy Market Size (2015-2020)
12.2 Monoclonal Antibody Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Monoclonal Antibody Therapy Market Size by Type (2015-2020)
12.4 Central & South America Monoclonal Antibody Therapy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbvie
13.1.1 Abbvie Company Details
13.1.2 Abbvie Business Overview
13.1.3 Abbvie Monoclonal Antibody Therapy Introduction
13.1.4 Abbvie Revenue in Monoclonal Antibody Therapy Business (2015-2020))
13.1.5 Abbvie Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview
13.2.3 Amgen Monoclonal Antibody Therapy Introduction
13.2.4 Amgen Revenue in Monoclonal Antibody Therapy Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 Glaxosmithkline
13.3.1 Glaxosmithkline Company Details
13.3.2 Glaxosmithkline Business Overview
13.3.3 Glaxosmithkline Monoclonal Antibody Therapy Introduction
13.3.4 Glaxosmithkline Revenue in Monoclonal Antibody Therapy Business (2015-2020)
13.3.5 Glaxosmithkline Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Monoclonal Antibody Therapy Introduction
13.4.4 Merck Revenue in Monoclonal Antibody Therapy Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Monoclonal Antibody Therapy Introduction
13.5.4 Novartis Revenue in Monoclonal Antibody Therapy Business (2015-2020)
13.5.5 Novartis Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Monoclonal Antibody Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Monoclonal Antibody Therapy Revenue
Table 3. Ranking of Global Top Monoclonal Antibody Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Monoclonal Antibody Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Recombinant
Table 6. Key Players of Chimeric
Table 7. Key Players of Humanized
Table 8. Key Players of Human
Table 9. Global Monoclonal Antibody Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Monoclonal Antibody Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Monoclonal Antibody Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Monoclonal Antibody Therapy Market Share by Regions (2015-2020)
Table 13. Global Monoclonal Antibody Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Monoclonal Antibody Therapy Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Monoclonal Antibody Therapy Market Growth Strategy
Table 19. Main Points Interviewed from Key Monoclonal Antibody Therapy Players
Table 20. Global Monoclonal Antibody Therapy Revenue by Players (2015-2020) (Million US$)
Table 21. Global Monoclonal Antibody Therapy Market Share by Players (2015-2020)
Table 22. Global Top Monoclonal Antibody Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapy as of 2019)
Table 23. Global Monoclonal Antibody Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Monoclonal Antibody Therapy Product Solution and Service
Table 26. Date of Enter into Monoclonal Antibody Therapy Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Monoclonal Antibody Therapy Market Size by Type (2015-2020) (Million US$)
Table 29. Global Monoclonal Antibody Therapy Market Size Share by Type (2015-2020)
Table 30. Global Monoclonal Antibody Therapy Revenue Market Share by Type (2021-2026)
Table 31. Global Monoclonal Antibody Therapy Market Size Share by Application (2015-2020)
Table 32. Global Monoclonal Antibody Therapy Market Size by Application (2015-2020) (Million US$)
Table 33. Global Monoclonal Antibody Therapy Market Size Share by Application (2021-2026)
Table 34. North America Key Players Monoclonal Antibody Therapy Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Monoclonal Antibody Therapy Market Share (2019-2020)
Table 36. North America Monoclonal Antibody Therapy Market Size by Type (2015-2020) (Million US$)
Table 37. North America Monoclonal Antibody Therapy Market Share by Type (2015-2020)
Table 38. North America Monoclonal Antibody Therapy Market Size by Application (2015-2020) (Million US$)
Table 39. North America Monoclonal Antibody Therapy Market Share by Application (2015-2020)
Table 40. Europe Key Players Monoclonal Antibody Therapy Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Monoclonal Antibody Therapy Market Share (2019-2020)
Table 42. Europe Monoclonal Antibody Therapy Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Monoclonal Antibody Therapy Market Share by Type (2015-2020)
Table 44. Europe Monoclonal Antibody Therapy Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Monoclonal Antibody Therapy Market Share by Application (2015-2020)
Table 46. China Key Players Monoclonal Antibody Therapy Revenue (2019-2020) (Million US$)
Table 47. China Key Players Monoclonal Antibody Therapy Market Share (2019-2020)
Table 48. China Monoclonal Antibody Therapy Market Size by Type (2015-2020) (Million US$)
Table 49. China Monoclonal Antibody Therapy Market Share by Type (2015-2020)
Table 50. China Monoclonal Antibody Therapy Market Size by Application (2015-2020) (Million US$)
Table 51. China Monoclonal Antibody Therapy Market Share by Application (2015-2020)
Table 52. Japan Key Players Monoclonal Antibody Therapy Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Monoclonal Antibody Therapy Market Share (2019-2020)
Table 54. Japan Monoclonal Antibody Therapy Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Monoclonal Antibody Therapy Market Share by Type (2015-2020)
Table 56. Japan Monoclonal Antibody Therapy Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Monoclonal Antibody Therapy Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Monoclonal Antibody Therapy Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Monoclonal Antibody Therapy Market Share (2019-2020)
Table 60. Southeast Asia Monoclonal Antibody Therapy Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Monoclonal Antibody Therapy Market Share by Type (2015-2020)
Table 62. Southeast Asia Monoclonal Antibody Therapy Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Monoclonal Antibody Therapy Market Share by Application (2015-2020)
Table 64. India Key Players Monoclonal Antibody Therapy Revenue (2019-2020) (Million US$)
Table 65. India Key Players Monoclonal Antibody Therapy Market Share (2019-2020)
Table 66. India Monoclonal Antibody Therapy Market Size by Type (2015-2020) (Million US$)
Table 67. India Monoclonal Antibody Therapy Market Share by Type (2015-2020)
Table 68. India Monoclonal Antibody Therapy Market Size by Application (2015-2020) (Million US$)
Table 69. India Monoclonal Antibody Therapy Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Monoclonal Antibody Therapy Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Monoclonal Antibody Therapy Market Share (2019-2020)
Table 72. Central & South America Monoclonal Antibody Therapy Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Monoclonal Antibody Therapy Market Share by Type (2015-2020)
Table 74. Central & South America Monoclonal Antibody Therapy Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Monoclonal Antibody Therapy Market Share by Application (2015-2020)
Table 76. Abbvie Company Details
Table 77. Abbvie Business Overview
Table 78. Abbvie Product
Table 79. Abbvie Revenue in Monoclonal Antibody Therapy Business (2015-2020) (Million US$)
Table 80. Abbvie Recent Development
Table 81. Amgen Company Details
Table 82. Amgen Business Overview
Table 83. Amgen Product
Table 84. Amgen Revenue in Monoclonal Antibody Therapy Business (2015-2020) (Million US$)
Table 85. Amgen Recent Development
Table 86. Glaxosmithkline Company Details
Table 87. Glaxosmithkline Business Overview
Table 88. Glaxosmithkline Product
Table 89. Glaxosmithkline Revenue in Monoclonal Antibody Therapy Business (2015-2020) (Million US$)
Table 90. Glaxosmithkline Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Product
Table 94. Merck Revenue in Monoclonal Antibody Therapy Business (2015-2020) (Million US$)
Table 95. Merck Recent Development
Table 96. Novartis Company Details
Table 97. Novartis Business Overview
Table 98. Novartis Product
Table 99. Novartis Revenue in Monoclonal Antibody Therapy Business (2015-2020) (Million US$)
Table 100. Novartis Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibody Therapy Market Share by Type: 2020 VS 2026
Figure 2. Recombinant Features
Figure 3. Chimeric Features
Figure 4. Humanized Features
Figure 5. Human Features
Figure 6. Global Monoclonal Antibody Therapy Market Share by Application: 2020 VS 2026
Figure 7. Diagnostic Test Case Studies
Figure 8. Analytical And Chemical Uses Case Studies
Figure 9. Cancer Treatment Case Studies
Figure 10. Autoimmune Diseases Case Studies
Figure 11. Hematological Disorders Case Studies
Figure 12. Monoclonal Antibody Therapy Report Years Considered
Figure 13. Global Monoclonal Antibody Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Monoclonal Antibody Therapy Market Share by Regions: 2020 VS 2026
Figure 15. Global Monoclonal Antibody Therapy Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Monoclonal Antibody Therapy Market Share by Players in 2019
Figure 18. Global Top Monoclonal Antibody Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapy as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Monoclonal Antibody Therapy Revenue in 2019
Figure 20. North America Monoclonal Antibody Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Monoclonal Antibody Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Monoclonal Antibody Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Monoclonal Antibody Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Monoclonal Antibody Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Monoclonal Antibody Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Monoclonal Antibody Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
【掲載企業】
Abbvie、Amgen、Glaxosmithkline、Merck、Novartis